THE STRUCTURE AND FUNCTION OF ALBICIN: A NEW WORLD ANOPHELINE MOSQUITO SALIVARY PROTEIN THAT INHIBITS OF THE ALTERNATIVE PATHWAY OF THE HUMAN COMPLEMENT

被引：0
|
作者：
Strayer, Ethan [1 ]
Andersen, John [1 ]
机构：
[1] NIAID, Lab Malaria & Vector Res, Rockville, MD USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 97卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1462
引用
收藏
页码：454 / 454
页数：1
相关论文
共 45 条
  • [41] SURFACE-ASSOCIATED HEPARIN INHIBITS ZYMOSAN-INDUCED ACTIVATION OF THE HUMAN ALTERNATIVE COMPLEMENT PATHWAY BY AUGMENTING THE REGULATORY ACTION OF THE CONTROL PROTEINS ON PARTICLE-BOUND C3B
    KAZATCHKINE, MD
    FEARON, DT
    SILBERT, JE
    AUSTEN, KF
    JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 150 (05): : 1202 - 1215
  • [42] The human complement receptor type 2/factor H fusion protein TT30, an alternative pathway specific complement inhibitor, prevents hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria by membrane-targeting of factor H activity
    Risitano, Antonio M.
    Pascariello, Caterina
    Selleri, Carmine
    Del Vecchio, Luigi
    Sica, Michela
    Fridkis-Hareli, Masha
    Mazsaroff, Istvan
    Horvath, Christopher J.
    Holers, V. Michael
    MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2215 - 2215
  • [43] The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models
    Fridkis-Hareli, Masha
    Storek, Michael
    Or, Eran
    Altman, Richard
    Katti, Suresh
    Sun, Fang
    Peng, Tao
    Hunter, Jeff
    Johnson, Krista
    Wang, Yi
    Lundberg, Ante S.
    Mehta, Gaurav
    Banda, Nirmal K.
    Holers, V. Michael
    MOLECULAR IMMUNOLOGY, 2019, 105 : 150 - 164
  • [44] Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1 and other members of their new family of G protein-linked receptors: Structure-function relationship with special reference to the human VIP-1 receptor
    Laburthe, M
    Couvineau, A
    Gaudin, P
    Maoret, JJ
    RouyerFessard, C
    Nicole, P
    VIP, PACAP, AND RELATED PEPTIDES, 2ND INTERNATIONAL SYMPOSIUM, 1996, 805 : 94 - 111
  • [45] The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer models and acts by CR2-dependent targeting of CR1 regulatory activity
    Holers, Michael
    Banda, Nirmal
    Mehta, Gaurav
    Fridkis-Hareli, Masha
    Or, Eran
    Storek, Michael
    Altman, Richard
    Johnson, Krista
    Katti, Suresh
    IMMUNOBIOLOGY, 2012, 217 (11) : 1210 - 1210
12345